Intelgenx Technologies Corp (IGXT)
0.1619
-0.02
(-9.30%)
USD |
OTCM |
May 03, 16:00
Intelgenx Technologies Shareholders Equity (Quarterly): -12.25M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -12.25M |
September 30, 2023 | -10.91M |
June 30, 2023 | -9.155M |
March 31, 2023 | -6.313M |
December 31, 2022 | -3.423M |
September 30, 2022 | -1.128M |
June 30, 2022 | 1.645M |
March 31, 2022 | 0.614M |
December 31, 2021 | 3.871M |
September 30, 2021 | 5.213M |
June 30, 2021 | 6.84M |
March 31, 2021 | -3.041M |
December 31, 2020 | -0.953M |
September 30, 2020 | -0.087M |
June 30, 2020 | 1.434M |
March 31, 2020 | 2.714M |
December 31, 2019 | 0.293M |
September 30, 2019 | 2.639M |
June 30, 2019 | 5.418M |
March 31, 2019 | 7.802M |
December 31, 2018 | 9.987M |
September 30, 2018 | 0.448M |
June 30, 2018 | 1.675M |
March 31, 2018 | 1.933M |
December 31, 2017 | 3.829M |
Date | Value |
---|---|
September 30, 2017 | 4.79M |
June 30, 2017 | 5.166M |
March 31, 2017 | 4.984M |
December 31, 2016 | 4.945M |
September 30, 2016 | 4.85M |
June 30, 2016 | 4.143M |
March 31, 2016 | 4.92M |
December 31, 2015 | 5.564M |
September 30, 2015 | 5.306M |
June 30, 2015 | 4.091M |
March 31, 2015 | 4.216M |
December 31, 2014 | 4.573M |
September 30, 2014 | 4.893M |
June 30, 2014 | 5.566M |
March 31, 2014 | 5.431M |
December 31, 2013 | 5.008M |
September 30, 2013 | 2.728M |
June 30, 2013 | 2.505M |
March 31, 2013 | 1.869M |
December 31, 2012 | 2.178M |
September 30, 2012 | 2.50M |
June 30, 2012 | 2.972M |
March 31, 2012 | 3.661M |
December 31, 2011 | 3.904M |
September 30, 2011 | 3.517M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-12.25M
Minimum
Dec 2023
6.84M
Maximum
Jun 2021
-0.8722M
Average
0.293M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 5.845M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.282M |
Total Liabilities (Quarterly) | 20.53M |
Debt to Equity Ratio | -1.216 |
Current Ratio | 0.4085 |
Net Debt Paydown Yield | -4.29% |